HUMMINGBIRD BIOSCIENCE

Hummingbird Bioscience is leading a bold new way of engineering precision biotherapeutics that can define the future of precision medicine. We focus on important biologically validated targets in cancer and autoimmune disease which have been elusive and difficult to drug. Powered by our unique data-driven systems biology approach, we engineer and develop next-generation therapies against these targets, giving hope to patients who do not respond to current treatments... We are a clinical-stage biotechnology company with a proprietary and differentiated Rational Antibody Discovery (RAD) platform, developing a broad pipeline of novel, precision therapeutics for the treatment of cancer and autoimmune disease.

Also known as: Hummingbird Bioscience Group, Hummingbird Bioscience Holdings Limited

Registration numbers: 201505192N (W)

Primary location: Houston United States